Dividend30 Jul 2026, 02:43 pm
Ajanta Pharma Declares ₹32/Share Interim Dividend
AI Summary
Ajanta Pharma Ltd. announced its Q1 FY27 results, reporting a 25% increase in revenue to ₹1,626 crore and a 31% rise in Profit After Tax (PAT) to ₹334 crore compared to Q1 FY26. The Board of Directors approved a first interim dividend of ₹32 per share for FY27, amounting to ₹400 crore. The record date for this dividend is August 5, 2026, with payment expected on or after August 18, 2026. The company also highlighted strong performance in its branded generics business across India, Asia, and Africa, with significant growth in the US generic market.
Key Highlights
- Q1 FY27 revenue up 25% to ₹1,626 cr.
- Q1 FY27 PAT increased 31% to ₹334 cr.
- First interim dividend of ₹32 per share declared.
- Total dividend payout of ₹400 crore approved.
- Record date set for August 5, 2026.
Price Impact
More from AJANTPHARM